News &amp; Updates

Pharmacist improves safety, quality of care in onco-haematology, bone marrow transplant units

Pharmacist interventions done in onco-haematology and bone marrow transplant inpatient units have led to improvements in safety and quality of care, results of a recent study have shown.

Pharmacist improves safety, quality of care in onco-haematology, bone marrow transplant units

Vitamin D helps fight colorectal cancer, precursor lesions in young women

Increased intake of vitamin D appears to reduce the risk of developing early-onset colorectal cancer and its precursor lesions in young women, as suggested in a study.

Vitamin D helps fight colorectal cancer, precursor lesions in young women

Is it safe to administer pegfilgrastim upon completion of 5-fluorouracil infusion?

It is safe to administer pegfilgrastim on the final day of 5-fluorouracil (5-FUCI), as suggested by the low risk of grade 3 and 4 neutropaenia, febrile neutropaenia, and dose delays or reduction, according to a recent study.

Is it safe to administer pegfilgrastim upon completion of 5-fluorouracil infusion?

Nonselective beta blockers may protect against liver cancer in patients with cirrhosis

Nonselective beta-blockers, including carvedilol, appear to lower the risk of hepatocellular cancer in patients with cirrhosis, according to a study.

Nonselective beta blockers may protect against liver cancer in patients with cirrhosis

Nivo–ipi, nivo–chemo present new first-line treatments for advanced oesophageal SCC

14 Jul 2021 by

The combination of nivolumab–ipilimumab (nivo–ipi) or nivolumab–chemotherapy (nivo–chemo) improved overall survival (OS) compared with chemotherapy alone in the first-line treatment of advanced oesophageal squamous cell carcinoma (ESCC), results of the phase III CheckMate 648 study showed.

Nivo–ipi, nivo–chemo present new first-line treatments for advanced oesophageal SCC

Medication reconciliation needed to curb high discrepancy rates in cancer patients

Medication discrepancies, such as unintentional omissions, frequently occur among hospitalized cancer patients, results of a recent study have shown. In addition, undocumented intentional discrepancies can likewise harm this critically ill population.

Medication reconciliation needed to curb high discrepancy rates in cancer patients

Chemo safe, effective when given 12 to 14 days from pegfilgrastim use

Dose-dense chemotherapy regimens administered less than 2 weeks from pegfilgrastim use remains safe and effective in patients with breast cancer, suggests a study at a multi-hospital health system.

Chemo safe, effective when given 12 to 14 days from pegfilgrastim use

Smartphone app monitors chemo-induced peripheral neuropathy

14 Jul 2021 by

Remote assessment of severe chemotherapy-induced peripheral neuropathy (CIPN) is feasible through NeuroDetect, a novel smartphone app, according to a recent study. Functional assessments through the app could help catch CIPN manifestations in the hands and feet early.

Smartphone app monitors chemo-induced peripheral neuropathy

Ibrutinib may promote hypertension

Use of ibrutinib appears to contribute to an increased risk of developing hypertension or blood pressure elevation, according to a study.

Ibrutinib may promote hypertension